afamelanotide (Scenesse)

afamelanotide · Clinuvel Pharmaceuticals Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for afamelanotide (Scenesse), covering 2013-03-22 to 2013-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo [Phase 2]